Takeda Pharmaceuticals Europe Ltd.
GPTKB entity
Statements (56)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
gptkb:Shire_plc
Acquired Envoy Therapeutics in 2016 Acquired Shire in 2019 Acquired_Ariad_Pharmaceuticals_in_2017 Acquired_Nycomed_in_2011 Acquired_TiGenix_in_2018 |
gptkbp:awards |
received accolades for workplace culture
recognized for innovation in pharmaceuticals awarded for corporate social responsibility won awards for diversity and inclusion initiatives |
gptkbp:CEO |
gptkb:Christophe_Weber
|
gptkbp:clinicalTrials |
conducts numerous clinical trials
|
gptkbp:communityInvolvement |
engages in local community projects
supports various health initiatives |
gptkbp:employees |
over 30,000
|
gptkbp:focusesOn |
biopharmaceuticals
|
gptkbp:founded |
1781
|
gptkbp:globalPresence |
operates in over 70 countries
|
gptkbp:headCoach |
approximately 50,000 globally
|
gptkbp:headquarters |
gptkb:Zurich,_Switzerland
|
https://www.w3.org/2000/01/rdf-schema#label |
Takeda Pharmaceuticals Europe Ltd.
|
gptkbp:investmentFocus |
invests heavily in R&D
invests in sustainable practices invests in digital health technologies invests in patient-centric solutions |
gptkbp:mission |
to strive towards better health for people worldwide
|
gptkbp:operatesIn |
Europe
|
gptkbp:parentCompany |
gptkb:Takeda_Pharmaceutical_Company_Limited
|
gptkbp:partnerships |
biotech companies
various academic institutions |
gptkbp:products |
vaccines
oncology drugs gastroenterology drugs rare diseases drugs |
gptkbp:research_areas |
oncology
rare diseases neuroscience gastroenterology |
gptkbp:researchAndDevelopment |
focus on neuroscience
focus on immunology focus on hematology |
gptkbp:revenue |
$17.3 billion (2022)
|
gptkbp:stockSymbol |
4502 (TSE)
TAK_(NYSE) |
gptkbp:subsidiary |
gptkb:Takeda_Pharmaceutical_Company_Limited
|
gptkbp:sustainabilityInitiatives |
community engagement
environmental responsibility patient access programs |
gptkbp:values |
honesty
teamwork fairness integrity perseverance |
gptkbp:vision |
to be a global leader in the biopharmaceutical industry
|
gptkbp:website |
www.takeda.com
|